增强亚慢性心肌梗塞,远程和健康心肌之间的对比,在旋转框架中使用周期性辐射
Elias Ylä-Herttuala1, Iida Räty1, Ahmed Montaser1
1University of Eastern Finland.
Research square
|September 26, 2025
概括
在排名2 (RAFF2) MRI的旋转框架中,随着虚拟场的放松而改变脉冲持续时间,提高了对心肌梗塞 (MI) 检测的对比度. 这项技术为评估受损心脏组织中的分子动力学提供了一种新的方法.
科学领域:
- 生物医学成像技术 生物医学成像技术
- 心血管研究研究心血管研究
- 磁共振成像是一种磁共振成像技术.
背景情况:
- 与纤维化相关的心肌病需要先进的特征化方法.
- 在2级旋转框架中沿虚拟场进行放松 (RAFF2) MRI对分子动态敏感.
- 通过优化MRI技术,可以改善心肌梗塞 (MI) 检测.
研究的目的:
- 为了研究改变RAFF2脉冲持续时间对心肌梗塞的表征的影响.
- 评估RAFF2对心肌梗塞分子动态的敏感性.
- 为了增强健康和心肌梗塞组织之间的MRI对比度.
主要方法:
- 在冠状动脉封闭7天后,RAFF2MRI序列应用于小鼠的心脏.
- 从0.6-2.0的拉伸系数 (TL) 被测试为α2 = 45°.
- 测量了相对放松时间差异 (RRTD),以量化MI和偏远地区之间的对比度.
主要成果:
- 在特定RAFF2脉冲持续时间 (TL0.6,TL0.8,TL1.8,TL2.0) 的MI区域观察到放松时间常数和RRTD的显著增加.
- 发现肌纤维素蛋白在MI区域上调调节.
- 改变RAFF2脉冲持续时间可以捕捉心肌内MI区域.
结论:
- 修改RAFF2脉冲持续时间可以增强MRI对比度,以区分心肌梗塞,远程心肌和健康心肌.
- 这种方法为评估MI中的分子动态提供了一种新的方法.
- 这些发现得到了其他MRI方法,蛋白质分析和组织学剖析的证实.
更多相关视频
08:43Advanced Cardiac Rhythm Management by Applying Optogenetic Multi-Site Photostimulation in Murine Hearts
Published on: August 26, 2021
2.8K
12:15Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease
Published on: February 8, 2022
2.9K
相关概念视频
Pulse rhythm
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
